Home
NICE Guidance
Published Guidance

Infliximab for subacute manifestations of ulcerative colitis

Technology appraisal guidance [TA140] Published date: 23 April 2008

Overview

Guidance

This guidance has been updated and replaced by NICE technology appraisal guidance 329.

About NICE
Into practice
News
Contact us
Leave feedback
Jobs

Newsletters and alerts
Twitter
YouTube
LinkedIn
Facebook

Explore

Guidance
Pathways
Standards and indicators
Savings and productivity
Evidence search
BNF
BNFC
Clinical knowledge summaries
Journals and databases

Syndication services

Access select services and content that NICE provides in a variety of formats.

Guidance app

Android
iOS

Get involved

Register as a stakeholder
Citizens council
Consultations
Fellows and scholars
Join a committee
Meetings in public
Student champions
Tenders
Public involvement

Accessibility
Freedom of information
Re-using our content
Glossary
Terms and conditions

Copyright © 2016 National Institute for Health and Care Excellence. All rights reserved.